Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer
Anticancer Research · 2026
DOI: 10.21873/anticanres.18190 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Anticancer Research, 2026. Verfasst von Kazuki Maeda und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Pancreatic Neoplasms, Vomiting, Morpholines.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.
- Clinical Research Centre for Developmental Therapeutics, Tokushima University Hospital, Tokushima, Japan.
- Department of Clinical Pharmacy Practice Pedagogy, Tokushima University, Tokushima, Japan.
- Department of Clinical Pharmacology and Therapeutics, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan; kawada.kei@tokushima-u.ac.jp.
- Department of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
- Department of Pharmaceutical Sciences for Health Crisis Management, Faculty of Pharmaceutical Sciences, Fukuoka University, Fukuoka, Japan.
Zitieren
APA
Maeda, K., Koyama, S., Kawada, K., Hayashi, T., Yoshioka, T., Ishida, T., Fukuda, H., Horikawa, I. O., Aizawa, F., Niimura, T., Yagi, K., Goda, M., Izawa-Ishizawa, Y., Abe, S., & Ishizawa, K. (2026). Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.18190
Vancouver
Maeda K, Koyama S, Kawada K, Hayashi T, Yoshioka T, Ishida T, et al. Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer. Anticancer Research. 2026. doi:10.21873/anticanres.18190
BibTeX
@article{Maeda2026,
author = {Maeda, Kazuki and Koyama, Sota and Kawada, Kei and Hayashi, Toshinobu and Yoshioka, Toshihiko and Ishida, Tomoaki and Fukuda, Hitoshi and Horikawa, I O and Aizawa, Fuka and Niimura, Takahiro and Yagi, Kenta and Goda, Mitsuhiro and Izawa-Ishizawa, Yuki and Abe, Shinji and Ishizawa, Keisuke},
title = {Fosnetupitant Versus Fosaprepitant for Delayed Vomiting Upon Irinotecan–Oxaliplatin Combination Chemotherapy for Pancreatic/Colorectal Cancer},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.18190}
}
EUVIMED